Group One Trading
PTLA

Group One Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Group One Trading’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-187,800
Closed -$3.38M – 6853
2020
Q2 		$3.38M Buy
187,800
+130,700
+229% +$1.82M 0.02% 1081
2020
Q1 		$407K Sell
57,100
-9,800
-15% -$122K ﹤0.01% 2201
2019
Q4 		$1.6M Buy
66,900
+14,500
+28% +$400K 0.01% 1476
2019
Q3 		$1.41M Buy
52,400
+28,800
+122% +$808K 0.01% 1475
2019
Q2 		$640K Buy
23,600
+3,400
+17% +$107K 0.01% 1920
2019
Q1 		$701K Sell
20,200
-26,500
-57% -$765K 0.01% 1683
2018
Q4 		$912K Sell
46,700
-3,400
-7% -$69.9K 0.01% 1574
2018
Q3 		$1.33M Buy
50,100
+7,000
+16% +$229K 0.01% 1468
2018
Q2 		$1.63M Sell
43,100
-82,700
-66% -$3.16M 0.01% 1291
2018
Q1 		$4.11M Buy
125,800
+24,900
+25% +$1.09M 0.04% 576
2017
Q4 		$4.91M Buy
100,900
+34,900
+53% +$1.77M 0.03% 652
2017
Q3 		$3.57M Buy
66,000
+14,400
+28% +$845K 0.03% 680
2017
Q2 		$2.9M Buy
51,600
+31,200
+153% +$1.25M 0.03% 738
2017
Q1 		$799K Sell
20,400
-13,500
-40% -$430K 0.01% 1498
2016
Q4 		$761K Sell
33,900
-4,600
-12% -$89.9K 0.01% 1493
2016
Q3 		$874K Buy
38,500
+33,700
+702% +$791K 0.01% 1368
2016
Q2 		$113K Sell
4,800
-34,400
-88% -$849K ﹤0.01% 2784
2016
Q1 		$800K Buy
39,200
+38,100
+3,464% +$1.21M 0.01% 1339
2015
Q4 		$57K Sell
1,100
-1,600
-59% -$77.6K ﹤0.01% 3335
2015
Q3 		$115K Buy
2,700
+700
+35% +$33.8K ﹤0.01% 2951
2015
Q2 		$91K Buy
2,000
+900
+82% +$36.2K ﹤0.01% 3157
2015
Q1 		$42K Sell
1,100
-19,100
-95% -$656K ﹤0.01% 3467
2014
Q4 		$572K Buy
20,200
+11,400
+130% +$317K 0.01% 1457
2014
Q3 		$222K Buy
8,800
+4,500
+105% +$119K ﹤0.01% 2291
2014
Q2 		$125K Buy
4,300
+3,100
+258% +$75K ﹤0.01% 2783
2014
Q1 		$31K Buy
+1,200
New +$32K ﹤0.01% 3972

Group One Trading's PTLA Position: Q3 2020 in Review

Group One Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 56,437 shares — an estimated $1.01M sold.

Group One Trading first reported a position in PTLA in Q2 2014 and held it in 22 quarters. The position peaked at $5.66M in Q3 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Group One Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Group One Trading sold 56,437 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.01M.
  • Group One Trading first reported a position in Portola Pharmaceuticals, Inc. in Q2 2014 and held it in 22 quarters.
  • Group One Trading's Portola Pharmaceuticals, Inc. position peaked at $5.66M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Group One Trading's 13F filing for Q3 2020, filed 12 Nov 2020.